Haskap in Scientific Research
Haskap has been studied far less than it is marketed, and the honest version of its story is the more interesting one. Human trials of the berry itself are very few — the two below are the ones that exist in any usable form, and both are small. What haskap does have is a measured composition, and that is where its genuinely unusual features are. This page keeps three kinds of evidence apart instead of blending them: what has been measured in the fruit, what has been tested in people with haskap, and what has been shown for the compound class the berry happens to be rich in.
1. What has been measured in the berry
Across 30 cultivars and genotypes, total anthocyanins ranged from 150.04 to 653.95 mg per 100 g of fresh fruit, with cyanidin-3-O-glucoside as the dominant one. [1] In eleven cultivars grown in Lithuania — the closest published material to our own growing conditions — total phenolics ran from 364.02 to 784.5 mg per 100 g and total anthocyanins from 277.8 to 394.1 mg per 100 g, with anthocyanins making up 53.8 per cent of total phenolics on average. Among the organic acids citric acid dominated at an average of 769.41 mg per 100 g, with malic acid at 289.90 and quinic acid at 45.00 mg per 100 g — which is most of the reason the berry tastes as sharp as it does. [2]
2. Vitamin C: one averaged figure, and what it does not cover
In those eleven Lithuanian cultivars, vitamin C averaged 34.26 mg per 100 g of fresh fruit. [2] Two things follow from a single averaged number like that, and both are worth saying out loud. It is an average across cultivars rather than a property of the species, so it says less about any particular berry than it looks like it does. And it is a figure for fresh fruit, not for pressed and pasteurised juice: vitamin C degrades during pressing, heat treatment and storage. A statement about the vitamin C content of a juice has to rest on that juice being measured, and this page does not make one.
3. The iridoids, which almost nothing it gets compared with has
In the same survey of 30 cultivars, fifty compounds were identified, among them fifteen iridoids — and two of those, 8-epi-loganic acid and pentosyl-loganic acid, were described in haskap for the first time in that paper. Total quantified iridoids ranged from 128.42 to 372 mg per 100 g of fresh fruit, with loganic acid accounting for between 22 and 73 per cent of them depending on cultivar. [1] Iridoids are bitter, and they are the part of haskap's flavour that no amount of sweetness covers. They are also largely absent from the other dark berries haskap sits beside on a shelf, which makes them the most genuinely distinctive thing about it.
4. Whether the dominant anthocyanin is actually absorbed
This has been tested directly, with a carbon-13 label rather than by inference. Eight participants took a single 500 mg dose of 13C5-labelled cyanidin-3-glucoside. Relative bioavailability came out at 12.38 per cent and total recovery across urine, breath and faeces at 43.9 per cent — with a range of 15.1 to 99.3 per cent between individuals, which is the part worth remembering. What circulates is largely not the intact anthocyanin but its degradation products: phenolic, hippuric, phenylacetic and phenylpropenoic acids, still measurable in blood up to 48 hours after a single dose. [3] Anthocyanins are more bioavailable than they were once thought to be, and also far less recognisable by the time they arrive anywhere.
5. Endurance running: the first of the two human trials
In a double-blind, placebo-controlled, independent-groups study, 30 male recreational runners received either a haskap berry intervention or an isocaloric placebo. Time to exhaustion in a peak oxygen uptake test was 20 seconds longer in the haskap group (p=0.031), and 5 km time trial performance improved by around 21 seconds (p=0.016) — a 0.25 km/h increase in mean running speed, which the authors describe as an improvement of more than 2 per cent. Heart rate and oxygen uptake showed modest changes at submaximal intensities (p<0.05). [4] What the trial did not do matters as much: it measured performance, not recovery, and it did not measure inflammatory or oxidative stress markers, so it cannot support anything about either.
6. Memory: the second trial, and what one acute dose can carry
A double-blind crossover pilot gave 20 adults aged 62 to 81 single doses of haskap extract containing 100, 200 or 400 mg of anthocyanins, with measurements 1.5 hours later. Word recall was significantly higher at both 200 and 400 mg and word recognition improved at 400 mg; the 400 mg dose also produced lower diastolic blood pressure and heart rate. Mood, working memory and executive function results were equivocal. [5] That is one acute dose in twenty people, measured once, ninety minutes later. It is a reason to keep studying the berry, not a claim about memory or blood pressure, and the authors frame it the same way.
7. Anthocyanins and cognition, as a compound class
Separately from haskap, a meta-analysis of 59 randomised controlled trials of anthocyanins and anthocyanin-rich foods found improved global cognition (standardised mean difference 0.46, 95% CI 0.30 to 0.63, I-squared 0.0 per cent), along with benefits for visuospatial processing and attention, processing and psychomotor speed, verbal fluency, episodic memory and working memory. [6] None of those 59 trials used haskap. That is why this section is numbered separately from the two above: it is evidence about the compound class haskap is rich in, and it belongs on this page as context rather than as a finding about this berry.
What has not been established
Almost everything else. A systematic review of 35 original papers on haskap's cardio-metabolic properties found the evidence base to consist of laboratory and animal work; there is no human cardiovascular or metabolic trial of haskap at all. [7] That covers cholesterol, blood sugar and metabolic markers: no human data. There is no chronic blood pressure trial, only the single acute dose in section 6. There is no human trial of haskap and eyesight, however often that claim appears. There is no human recovery or anti-inflammatory trial. And haskap has no authorised European health claim of its own.
Safety, and who should be careful
Haskap is a food eaten in ordinary quantities and is well tolerated. One point is worth stating plainly, because the family name invites a dangerous confusion: among the honeysuckles, it is Lonicera caerulea that bears edible fruit. Several related species, among them Lonicera xylosteum and Lonicera tatarica, carry red berries that cause vomiting and must not be eaten, and nothing on this page should be read as saying otherwise.
References
- Kucharska AZ, Sokol-Letowska A, Oszmianski J, Piorecki N, Fecka I. Iridoids, phenolic compounds and antioxidant activity of edible honeysuckle berries (Lonicera caerulea var. kamtschatica Sevast.). Molecules. 2017;22(3):405. PMID 28273885
- Cesoniene L, Labokas J, Jasutiene I, Sarkinas A, Kaskoniene V, Kaskonas P, Kazernaviciute R, Pazereckaite A, Daubaras R. Bioactive compounds, antioxidant, and antibacterial properties of Lonicera caerulea berries: evaluation of 11 cultivars. Plants (Basel). 2021;10(4):624. PMID 33806020
- Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a 13C-tracer study. Am J Clin Nutr. 2013;97(5):995–1003. PMID 23604435
- Howatson G, Snaith GC, Kimble R, Cowper G, Keane KM. Improved endurance running performance following haskap berry (Lonicera caerulea L.) ingestion. Nutrients. 2022;14(4):780. PMID 35215430
- Bell L, Williams CM. A pilot dose-response study of the acute effects of haskap berry extract (Lonicera caerulea L.) on cognition, mood, and blood pressure in older adults. Eur J Nutr. 2019;58(8):3325–3334. PMID 30535796
- Micek A, Godos J, Giampieri F, Battino M, Quiles JL, Del Rio D, Mena P, Caruso G, et al. The effect of anthocyanins and anthocyanin-rich foods on cognitive function: a meta-analysis of randomized controlled trials. Geroscience. 2026;48(5):6929–6963. PMID 41351717
- Bora L, Lombrea A, Batrina SL, Buda VO, Esanu OM, Pasca O, Dehelean CA, Dinu S, Diaconeasa Z, Danciu C. A systematic review of cardio-metabolic properties of Lonicera caerulea L. Antioxidants (Basel). 2024;13(6):694. PMID 38929133